Spasticity

CMAJ. 2015 Apr 7;187(6):436. doi: 10.1503/cmaj.140405. Epub 2014 Nov 17.

Authors

Raphael Rush¹, Dinesh Kumbhare²

Affiliations

¹ Department of Internal Medicine (Rush), University of Toronto; Department of Physical Medicine and Rehabilitation, Toronto Rehabilitation Institute, and University of Toronto (Kumbhare), Toronto, Ont. raphael.rush@mail.utoronto.ca.
² Department of Internal Medicine (Rush), University of Toronto; Department of Physical Medicine and Rehabilitation, Toronto Rehabilitation Institute, and University of Toronto (Kumbhare), Toronto, Ont.

No abstract available

MeSH terms

Baclofen / therapeutic use
Botulinum Toxins / therapeutic use
Cerebral Palsy / complications
Humans
Multiple Sclerosis / complications
Muscle Relaxants, Central / therapeutic use*
Muscle Spasticity / etiology
Muscle Spasticity / therapy*
Neuromuscular Agents / therapeutic use*
Physical Therapy Modalities*
Stroke / complications

Substances

Muscle Relaxants, Central
Neuromuscular Agents
Botulinum Toxins
Baclofen